NEO6860: A Phase I, Double-Blind, Placebo-Controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Male and Female Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs NEO 6860 (Primary)
Indications Musculoskeletal pain; Neuropathic pain; Osteoarthritis; Visceral pain
Focus Adverse reactions; First in man

20 Sep 2017 According to a NEOMED Institute media release, results from this trial will be presented at the Pain & Migraine Therapeutic Summit.
07 Feb 2017 Results published in the Journal of Pain : official journal of the American Pain Society.
14 May 2016 Results presented at the 35th Annual Scientific Meeting of the American Pain Society.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com